← Back to Search

Behavioral Intervention

Mobile App for PTSD

N/A

Waitlist Available

Led By Margaret R Emerson, DNP

Research Sponsored by University of Nebraska

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 8 months

Awards & highlights

Study Summary

This trial will test the feasibility and acceptability of a mobile app with automated assessment, treatment guidance, and in-app evidence-based treatment support for depression, PTSD, sleep difficulties, and anxiety among underserved patients with trauma histories in an integrated primary care setting.

Who is the study for?

This trial is for adults aged 19 or older who are being referred to a behavioral health provider and own a smartphone. They must have experienced significant childhood trauma, indicated by scoring at least 3 on the Adverse Childhood Experience screening. It's not for those under 19, with past year referrals to behavioral health, without a smartphone, low trauma scores, neurocognitive conditions, or high suicidality.Check my eligibility

What is being tested?

The BounceBack Now (BBN) mobile app is being tested for its ability to help manage depression, PTSD, sleep difficulties, and anxiety in patients with trauma histories. The study will develop educational materials and assess the app's feasibility and acceptability in an integrated primary care setting among underserved populations.See study design

What are the potential side effects?

Since BBN is a mental health mobile app focused on self-help treatment guidance rather than medication or invasive therapy, it may not have traditional side effects but could potentially lead to emotional discomfort or distress as individuals engage with their traumatic experiences during use.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 8 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~8 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Aim 1: Evaluation of Educational Materials

Aim 2: Acceptability: App use

Aim 2: Comfort Level

+4 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: BBN pilotExperimental Treatment1 Intervention

Deployment of BBN for patient use, self-paced

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

BBN for Trauma Informed Care

2022

N/A

~30

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of NebraskaLead Sponsor

539 Previous Clinical Trials

1,144,705 Total Patients Enrolled

Margaret R Emerson, DNPPrincipal InvestigatorUNMC

Margaret R Emerson, DNP, APRNPrincipal InvestigatorUniversity of Nebraska

Media Library

BBN for Trauma Informed Care (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05374408 — N/A

Post-Traumatic Stress Disorder Research Study Groups: BBN pilot

Post-Traumatic Stress Disorder Clinical Trial 2023: BBN for Trauma Informed Care Highlights & Side Effects. Trial Name: NCT05374408 — N/A

BBN for Trauma Informed Care (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05374408 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are new participants being welcomed for this research?

"Per the information available on clinicaltrials.gov, this trial is actively looking for participants and was initially posted on August 3rd 2022 with the last update occurring October 27th of that same year."

Answered by AI

How many research participants are included in this experimental protocol?

"Affirmative, the clinicaltrials.gov database shows that this ongoing study is actively recruiting patients. Initial posting was on August 3rd 2022 and has since been updated on October 27th 2022 - with a total of 29 participants needed from two trial sites."

Answered by AI